Effects of additives on the physical stability and dissolution of polymeric amorphous solid dispersions: A review

J Li, Y Wang, D Yu - AAPS PharmSciTech, 2023 - Springer
Polymeric amorphous solid dispersion (ASD) is a popular approach for enhancing the
solubility of poorly water-soluble drugs. However, achieving both physical stability and …

Physical stability and dissolution behaviors of amorphous pharmaceutical solids: Role of surface and interface effects

Q Shi, SM Moinuddin, Y Wang, F Ahsan, F Li - International Journal of …, 2022 - Elsevier
Amorphous pharmaceutical solids (APS) are single-or multi-component systems in which
drugs exist in high-energy states with long-range disordered molecular packing. APSs have …

Anisotropic molecular organization at a liquid/vapor interface promotes crystal nucleation with polymorph selection

X Yao, Q Liu, B Wang, J Yu, MM Aristov… - Journal of the …, 2022 - ACS Publications
The molecules at the surface of a liquid have different organization and dynamics from those
in the bulk, potentially altering the rate of crystal nucleation and polymorphic selection, but …

Impact of crystal nuclei on dissolution of amorphous drugs

X Yao, L Yu, GGZ Zhang - Molecular Pharmaceutics, 2023 - ACS Publications
Amorphous drugs are used to improve bioavailability of poorly water-soluble drugs.
Crystallization must be managed to take full advantage of this formulation strategy …

[HTML][HTML] Surface-enhanced crystal nucleation and polymorph selection in amorphous posaconazole

X Yao, KA Borchardt, Y Gui, IA Guzei… - The Journal of …, 2022 - pubs.aip.org
Molecules at a liquid/vapor interface have different organizations and mobilities from those
in the bulk. These differences potentially influence the rate of crystal nucleation, but the …

Amorphous drug–polymer salts: Maximizing proton transfer to enhance stability and release

AL Neusaenger, X Yao, J Yu, S Kim… - Molecular …, 2023 - ACS Publications
An amorphous drug–polymer salt (ADPS) can be remarkably stable against crystallization at
high temperature and humidity (eg, 40° C/75% RH) and provide fast release. Here, we …

Drug release from surfactant-containing amorphous solid dispersions: mechanism and role of surfactant in release enhancement

R Yang, GGZ Zhang, DY Zemlyanov, HS Purohit… - Pharmaceutical …, 2023 - Springer
Purpose To understand how surfactants affect drug release from ternary amorphous solid
dispersions (ASDs), and to investigate different mechanisms of release enhancement …

Surfactants accelerate crystallization of amorphous nifedipine by similar enhancement of nucleation and growth independent of hydrophilic–lipophilic balance

X Yao, EG Benson, Y Gui, T Stelzer… - Molecular …, 2022 - ACS Publications
Amorphous formulations, increasingly employed to deliver poorly soluble drugs, generally
contain surfactants to improve wetting and dissolution. These surfactants are often liquids …

Formulation and processing strategies which underpin susceptibility to matrix crystallization in amorphous solid dispersions

DE Moseson, TN Hiew, Y Su, LS Taylor - Journal of pharmaceutical …, 2023 - Elsevier
Through matrix crystallization, an amorphous solid may transform directly into its more stable
crystalline state, reducing the driving force for dissolution. Herein, the mechanism of matrix …

Amorphous drug–polymer salt with high stability under tropical conditions and fast dissolution: the challenging case of lumefantrine-PAA

X Yao, S Kim, Y Gui, Z Chen, J Yu, KJ Jones… - Journal of Pharmaceutical …, 2021 - Elsevier
Abstract Lumefantrine (LMF), a high-mobility and easy-to-crystallize WHO drug for treating
malaria, can form an amorphous salt with poly (acrylic acid)(PAA) that is remarkably stable …